GRK3 Gene

Name G protein-coupled receptor kinase 3
Description The beta-adrenergic receptor kinase specifically phosphorylates the agonist-occupied form of the beta-adrenergic and related G protein-coupled receptors. Overall, the beta adrenergic receptor kinase 2 has 85% amino acid similarity with beta adrenergic receptor kinase 1, with the protein kinase catalytic domain having 95% similarity. These data suggest the existence of a family of receptor kinases which may serve broadly to regulate receptor function. [provided by RefSeq, Jul 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n G protein‐coupled receptor kinase 3 (GRK3) is emerging as a central modulator of G protein–coupled receptor (GPCR) signaling whose activity coordinates receptor phosphorylation, desensitization, internalization, and subsequent regulation of downstream signaling cascades in diverse physiological systems. For example, in leukocytes GRK3 phosphorylates and thereby promotes the internalization and desensitization of the chemokine receptor CXCR4; loss or reduced expression of GRK3 enhances CXCL12‐driven chemotaxis, as observed in WHIM syndrome, while restoration of GRK3 levels normalizes receptor function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In stress‐related neuroendocrine circuits, GRK3, acting in tandem with GRK6 and β‐arrestin, is essential for homologous desensitization of corticotropin‐releasing factor receptors, thereby contributing to the dynamic regulation of stress hormone signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, GRK3 maturation is supported by its interaction with heat shock proteins, which helps stabilize the kinase and ensures proper regulation of receptor activity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In immune cells such as mast cells, GRK3—together with GRK2—plays a pivotal role in shaping intracellular calcium mobilization, receptor desensitization, degranulation, and mitogen‐activated protein kinase activation downstream of receptors like C3aR."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " In oncology, aberrant GRK3 expression has been linked to metastatic progression; in triple‐negative breast cancer, altered GRK3 levels affect CXCR4‐mediated migration and invasion, while in prostate cancer overexpression of GRK3 promotes neuroendocrine differentiation and enhances metastasis in part by modulating angiogenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "8"}]}, {"type": "t", "text": " Similarly, in chemokine scavenging, GRK3 is selectively recruited to atypical chemokine receptor 4 (ACKR4) following ligand engagement, where it coordinates subsequent β‐arrestin binding and receptor trafficking."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n GRK3 also regulates opioid receptor signaling; for instance, phosphorylation of the nociceptin receptor at critical C‐terminal sites by GRK3 enables β‐arrestin–dependent internalization and specific downstream MAP kinase activation, a process that contributes to ligand‐directed modulation of receptor responsiveness."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " In neurological and psychiatric contexts, decreased GRK3 expression has been associated with glioblastoma and may influence receptor dysregulation in neuropsychiatric disorders such as schizophrenia"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": ", while genetic studies have also implicated GRK3 as a candidate gene in affective disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Finally, GRK3 contributes to the regulation of mu‐opioid receptor signaling whereby GRK3‐dependent activation of c‐Jun N‐terminal kinase 2 (JNK2) has been shown to underlie mechanisms of morphine tolerance"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", and its expression levels in lymphocytes correlate inversely with blood pressure, suggesting a protective vascular role."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings underscore the multifaceted roles of GRK3 in GPCR desensitization and signal modulation across immune, endocrine, neural, and oncogenic pathways, highlighting its potential as a therapeutic target for conditions ranging from immunodeficiency and cancer metastasis to opioid tolerance and neuropsychiatric disorders.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Karl Balabanian, Angélique Levoye, Lysiane Klemm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI33187"}], "href": "https://doi.org/10.1172/JCI33187"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18274673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18274673"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Peter J McCormick, Marta Segarra, Paola Gasperini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0008102"}], "href": "https://doi.org/10.1371/journal.pone.0008102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19956569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19956569"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Thalia Teli, Danijela Markovic, Michael A Levine, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2004-0275"}], "href": "https://doi.org/10.1210/me.2004-0275"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15498832"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15498832"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jiansong Luo, Jeffrey L Benovic "}, {"type": "b", "children": [{"type": "t", "text": "G protein-coupled receptor kinase interaction with Hsp90 mediates kinase maturation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M307637200"}], "href": "https://doi.org/10.1074/jbc.M307637200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14557268"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14557268"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Qiang Guo, Hariharan Subramanian, Kshitij Gupta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0022559"}], "href": "https://doi.org/10.1371/journal.pone.0022559"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21799898"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21799898"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Matthew J Billard, David J Fitzhugh, Joel S Parker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0152856"}], "href": "https://doi.org/10.1371/journal.pone.0152856"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27049755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27049755"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Meixiang Sang, Mohit Hulsurkar, Xiaochong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9359"}], "href": "https://doi.org/10.18632/oncotarget.9359"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27191986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27191986"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wenliang Li, Nanping Ai, Suming Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GRK3 is essential for metastatic cells and promotes prostate tumor progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1320638111"}], "href": "https://doi.org/10.1073/pnas.1320638111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24434559"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24434559"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Christoph Matti, Angela Salnikov, Marc Artinger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2020.00720"}], "href": "https://doi.org/10.3389/fimmu.2020.00720"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32391018"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32391018"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Nancy R Zhang, William Planer, Edward R Siuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.405696"}], "href": "https://doi.org/10.1074/jbc.M112.405696"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23086955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23086955"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "B Mark Woerner, Jingqin Luo, Kristin R Brown, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-11-0411"}], "href": "https://doi.org/10.1158/1541-7786.MCR-11-0411"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22086906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22086906"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "E R Bychkov, M R Ahmed, V V Gurevich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2011.07.009"}], "href": "https://doi.org/10.1016/j.nbd.2011.07.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21784156"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21784156"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "J J Luykx, M P M Boks, A P R Terwindt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Neuropsychopharmacol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.euroneuro.2010.02.008"}], "href": "https://doi.org/10.1016/j.euroneuro.2010.02.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20226637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20226637"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Matthew B Yuill, Michael L Zee, David Marcus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tolerance to the antinociceptive and hypothermic effects of morphine is mediated by multiple isoforms of c-Jun N-terminal kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroreport (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/WNR.0000000000000551"}], "href": "https://doi.org/10.1097/WNR.0000000000000551"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26914092"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26914092"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Eduardo Oliver, Eduardo Rovira, Fermí Montó, et al. "}, {"type": "b", "children": [{"type": "t", "text": "beta-Adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hypertens (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/HJH.0b013e3283383564"}], "href": "https://doi.org/10.1097/HJH.0b013e3283383564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20216086"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20216086"}]}]}]}
NCBI Gene ID 157
API
Download Associations
Predicted Functions View GRK3's ARCHS4 Predicted Functions.
Co-expressed Genes View GRK3's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View GRK3's ARCHS4 Predicted Functions.

Functional Associations

GRK3 has 2,573 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 44 datasets.

Click the + buttons to view associations for GRK3 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of GRK3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of GRK3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CellMarker Gene-Cell Type Associations cell types associated with GRK3 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of GRK3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of GRK3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with GRK3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of GRK3 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by GRK3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DGIdb Drug Targets 2026 interacting drugs for GRK3 protein from the DGIdb Drug Targets 2026 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with GRK3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with GRK3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding GRK3 protein from the GlyGen Glycosylated Proteins dataset.
GO Biological Process Annotations 2023 biological processes involving GRK3 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving GRK3 gene from the curated GO Biological Process Annotations2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by GRK3 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by GRK3 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of GRK3 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of GRK3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of GRK3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with GRK3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by GRK3 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of GRK3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of GRK3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
KEGG Pathways 2026 pathways involving GRK3 protein from the KEGG Pathways 2026 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of GRK3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of GRK3 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by GRK3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of GRK3 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of GRK3 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
PFOCR Pathway Figure Associations 2023 pathways involving GRK3 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving GRK3 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2024 pathways involving GRK3 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of GRK3 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of GRK3 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of GRK3 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of GRK3 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of GRK3 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of GRK3 gene from the Sci-Plex Drug Perturbation Signatures dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with GRK3 gene from the SynGO Synaptic Gene Annotations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of GRK3 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of GRK3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of GRK3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with GRK3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving GRK3 protein from the WikiPathways Pathways 2024 dataset.